Aktiesnakken — Juli 2011
-
41,99
-
42,2 (+4,2%)
-
Genmab og GSK kurs er nu samstemt
-
kursen på gsk og genmab er den samme nu
-
det var både for sjov
-
enig i at lifecycle pharma er klart undervurderet, men tror ikke der kommer til at ske det store i et stykke tid
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind